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White matter disease in preterm infants comes along with focal destructions or with diffuse
myelination disturbance. Recent experimental work with transgenic mice paves the way for
a unifying molecular model for both types of brain injury, placing oxygen sensing by oligo-
dendrocyte precursor cells (OPCs) at the center stage. Mice genetically altered to mimic
high local oxygen tension in oligodendroglia lineage cells (via deletion of hypoxia-inducible
factor, HIF) develop white matter disease resembling cystic periventricular leukomalacia
within the first 7 days of life. Mice in which local hypoxia is mimicked in oligodendroglial
cells (via genetic inhibition of HIF decay) display arrested OPC maturation and subsequent
hypomyelination, reminiscent of the diffuse white matter disease observed in preterm
infants and infants with congenital heart disease. These recent experimental findings on
oxygen sensing and myelination are awaiting integration into a clinical framework. Gene
regulation in response to hyperoxia or hypoxia, rather than oxidative stress, may be an
important mechanism underlying neonatal white matter disease.
Keywords: periventricular leukomalacia, white matter disease, hypoxia-inducible factor, oligodendrocyte precur-
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CYSTIC AND DIFFUSE WHITE MATTER DISEASE IN
NEWBORN INFANTS
Brain injury in preterm newborn infants involves both destruc-
tive and developmental disturbances (1). Cystic periventricular
leukomalacia (cPVL) and diffuse white matter disease (dWMD)
are increasingly being viewed as distinct nosological entities rather
representing various degrees of severity of the same disorder (2, 3).
cPVL is characterized by non-hemorrhagic necrotic lesions lead-
ing to non-selective destruction of all cellular elements, including
glia and blood vessels (1, 4). These lesions are usually detected
as clustered or sporadic porencephalic cysts by cranial ultrasound
during the second or third week of life (5). While the incidence of
cPVL declined in recent decades, with cPVL affecting now less than
5% of very low birth weight infants (6–9), it remains the strongest
predictor of severe cerebral palsy in preterm infants (10). Risk fac-
tors for cPVL differ from those of most other prematurity related
diseases, as rates of cPVL do not increase with low Apgar scores,
lack of antenatal steroids, institution or duration of mechanical
ventilation, male sex, or extremely low gestational age (11). Among
very low birth weight infants, rates of cPVL are not related to ges-
tational age (6, 11) while the overall risk of neurodevelopmental
impairment rises steadily with decreasing gestational age.
Evidence of dWMD has been revealed by advanced magnetic
resonance imaging techniques, notably diffusion tensor imaging
and magnetic resonance spectroscopy imaging, in many very low
birth weight preterm infants (9, 12–14). Moreover, magnetic reso-
nance imaging studies in infants with congenital heart disease have
revealed dWMD in a substantial proportion of these infants after
neonatal cardiac surgery (15, 16). Some of these lesions, however,
are present already before cardiac surgery (17–19). The clinical
sequelae of dWMD appear to be more subtle, as compared to those
of cPVL, and include cognitive and behavioral problems such as
attention deficits, hyperactivity, language impairments, and poor
processing of visual information (20–24). Autopsy findings point
to disturbed myelination, arising from failure of oligodendrocyte
precursor cells (OPCs) to generate myelinating oligodendrocytes,
as a key finding in dWMD (8). In contrast to cPVL, there is little
axonal degeneration (25) or loss of gray matter neurons in dWMD
(26). However, the complexity of dendritic arbors is reduced in
dWMD, and the transient failure to establish neuronal connections
is thought to underlie persistently altered brain circuitry (2).
OXYGEN-REGULATED GENE EXPRESSION
Changes of ambient oxygen tension cause a cellular response
orchestrated by hypoxia-inducible factors (HIFs) in almost all
mammalian cell types (27). The lack of oxygen (hypoxia) strongly
activates the master regulators HIF1 and HIF2, normal oxygen
tension or an excess in oxygen (hyperoxia) blocks the action
of both transcription factors. In detail, HIF1 and HIF2 are
two heterodimeric transcription factors consisting each of an
oxygen-regulated α-subunit (HIF1α and HIF2α) and an oxygen-
insensitive β-subunit. In the presence of oxygen, HIF1α and HIF2α
are permanently deactivated by two oxygen-dependent enzymes,
asparaginyl and prolyl hydroxylases. Asparagine hydroxylation of a
conserved residue inhibits the binding of HIF1αor HIF2α to its co-
activator p300/CREB-binding protein (28). Proline hydroxylation
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targets HIF1α or HIF2α for ubiquitination mediated by the von
Hippel–Lindau (VHL) ubiquitin ligase (29, 30), which in turn is
followed by proteasomal degradation (31). The enzymatic activ-
ity of both, the asparginyl and prolyl hydroxylase, is lowered or
even turned off at low oxygen tension, as they both use oxygen as
a substrate. Subsequently, spared HIF1α and HIF2α moieties are
then able to join oxygen-insensitive β subunits, translocate to the
nucleus, and activate a distinct gene response.
WHITE MATTER DISEASE IN MICE WITH GENETICALLY
ALTERED HIF METABOLISM
As intrauterine oxygen tension is difficult to manipulate in exper-
imental animals, researchers at the University of California in
San Francisco used mice with either targeted deletions of HIF1α
and HIF2α, or lack of VHL-mediated HIF1α/HIF2α decay in
the oligodendroglial lineage (32). Embryonic mice unable to
express HIF1α and HIF2α in oligodendroglial lineage cells, mim-
icking high local oxygen tension, had poor vascularization in the
white matter before birth, followed by severe neuroaxonal damage
and apoptotic cell death of microglia, astroglia, and oligoden-
droglia by day 4 of life, and ultimately acellular white matter
cysts by day 7 of life. In contrast, conditional oligodendroglial
HIF1α/HIF2αoverexpression mediated by VHL knockout resulted
in OPC maturation arrest and subsequent hypomyelination. By
using genetically engineered mice with manipulated HIF path-
ways but kept in normal air, the study specifically investigated
the effects of oxygen-sensitive gene regulation, as there was nei-
ther oxidative stress associated with excessive oxygen, nor low
intracellular energy stores occurring when oxygen supply fails
to meet demands. Nevertheless, the delayed OPC differentiation
and reduced expression of myelin basic protein observed with
VHL knockout-mediated HIF1α/HIF2α overexpression was also
observed in wild-type mice exposed to hypoxia (FiO2 0.1) between
day 3 and 11 of life.
The investigators went on to show that the regulation of
white matter vascularization and oligodendroglial maturation
in response to altered HIF1α/HIF2α is mediated by secreted
Wnt7a/7b glycoproteins in a paracrine or autocrine fashion,
respectively. Wnt7a/7b was previously implicated in oligoden-
droglial maturation and myelination (33, 34), as well as in white
matter vascularization (35), and the new work now demonstrates
its regulation by HIF1α/HIF2α. Chronic hypoxia (FiO2 0.1 for
6–72 h) has recently been shown to induce canonical (β-catenin-
dependent) Wnt signaling alongside increased cell proliferation in
the hippocampus of adult mice (36). In the white matter, the role
of Wnt7a/7b is reminiscent of vascular endothelial growth factor
(VEGF) as the classical HIF1α/HIF2α target that is involved in
angiogenesis and tissue architecture in the gray matter (37).
EFFECTS OF HYPOXIA OR HYPEROXIA ON THE BRAIN OF
NEWBORN RODENTS
In the report that first used the term“periventricular leukomalacia”
(38), the authors concluded from the location of the lesions at arte-
rial border zones that either a lack of oxygen or an excess of oxygen
might contribute to the pathogenesis of the neonatal white matter
disease described (39). Mouse or rat pups subjected to antenatal
hypoxia (FiO2 0.1) show increased white matter vessel densities but
myelination deficits are only found in rat pups (40). The oligoden-
droglial maldevelopment and the delay of myelination observed
in neonatal rats are aggravated by postnatal hyperoxia (FiO2 0.6
for 7 days) but prevented by slowly increasing FiO2 from 0.15 to
0.21 during the first 7 days of life (41). Mice pups reared under
low oxygen (FiO2 0.1) between day 3 and day 11 of life display
reduced cortical gray and white matter volumes and delayed mat-
uration of OPCs (42). Experimental hypoxia, however, does not
elicit the cPVL-type focal necrotic lesions involving all cellular ele-
ments, unless cerebral blood supply is drastically perturbed (3). In
contrast, the clinical course of preterm infants subsequently diag-
nosed with cPVL is often inconspicuous, and their mean arterial
blood pressures during the first week of life are higher than those
of controls (11). A role for cerebral vessel constriction in precipi-
tating cPVL has been inferred from the relationship between cPVL
and hypocapnia during the first days of life (11, 43, 44) and the
increased rates of cerebral palsy and impaired neurodevelopment
associated with neonatal hypocapnia and hyperoxia (45, 46). The
work by Yuen et al. (32) suggests that degeneration of white mat-
ter vessels mediated by loss of trophic Wnt7a/7b stimulation in
response to relative hyperoxia may promote the focal ischemic
infarctions that underlie cPVL. cPVL thus joins retinopathy of
prematurity (ROP) as a disease of developing arterial blood vessel
that is driven by the rapid surge of oxygen tension that invariably
follows lung aeration after birth.
The transition from placental to pulmonary oxygenation causes
a rapid, drastic and persistent increase of oxygen tension. Oxygen
tensions measured in fetal brain are only 10–20% of those found
in adult brain (0.08–7.6 mmHg vs. 11–53 mmHg) (47), and the
huge oxygen leap after birth necessarily diminishes expression of
HIF1α/HIF2α-regulated genes. Human embryonic stem cells can
give rise to oligodendroglial lineage cells in vitro when cultured
at low oxygen of FiO2 0.03 but not at FiO2 0.21 (48, 49). In
preterm infants, developmental processes, which physiologically
ought to continue for several months under low oxygen conditions
(and therefore in the presence of high concentrations of VEGF,
Wnt7a/7b, and a multitude of other HIF1α/HIF2α-regulated gene
products) are suddenly disturbed or disrupted by premature birth
into room air, even if additional supply of oxygen is being avoided.
Restraint in using high FiO2 with careful monitoring of arterial
oxygen saturation by pulse oximetry might have contributed to
the decline of cPVL observed over the last decades (6–9).
While experimental hyperoxia in rodents is apt to reproduce
several findings of human ROP, exposure to neonatal rats or mice
to high oxygen does not necessarily generate the cystic white matter
lesions observed with gene-mediated HIF1α/HIF2α-suppression
in OPCs acting already before birth. While the brain matura-
tion of newborn rats and mice recapitulates many features of the
human situation during the last trimester of pregnancy and there-
fore that of preterm infants born 2–3 months early, the newborn
rodents used in experiments are physiologically adjusted to the
perinatal oxygen surge and thus potentially less vulnerable than
human preterm babies. Experimental hyperoxia at birth (FiO2
0.6), postnatal day 3 or day 6 (FiO2 0.6), but not day 10, has nev-
ertheless a deleterious effect on the developing white matter in
normal rat pups (41, 50). Grown-up mice (30 or 60 days old) pre-
viously exposed to hyperoxia (FiO2 0.8) at 6 days of life for 48 h
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continue to show signs of dWMD when examined by diffusion
tensor imaging (51) that reflect myelination abnormalities and
consecutive axonopathies (52). Cultured OPCs but not mature
oligodendrocytes undergo apoptotic cell death when directly sub-
jected to high oxygen (50, 53) but it is unknown whether this
also involves HIF1α/HIF2α-mediated downregulation of trophic
factors or other non-HIF1α/HIF2α-mediated mechanisms.
CONCLUDING REMARKS
In sum, the immature white matter of both human beings and
rodents is highly sensitive to altered oxygen tension during a criti-
cal developmental window prior to the onset of myelination. Both
too much and too little oxygen can cause damage by profoundly
altering expression of various genes, unrelated to any oxidative
stress. These two conditions may occur sequentially in the same
brain, as reduced vessel density after high oxygen subsequently
leads to low oxygen supply at a time when demand is on the rise.
Meticulous attempts to avoid extremes of oxygen tension in the
brains of preterm infants and in infants with congenital heart
disease undergoing surgery, possibly aided by directly monitor-
ing cerebral oxygenation (54), will hopefully further preserve their
white matter integrity.
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